Concepedia

Chuan-Gui Li

CL

Statistics

Publications

2

Citations

155

H-Index

2

Active since

2015

Affiliations

China Pharmaceutical University(Current)

Chuan-Gui Li is an author at China Pharmaceutical University specializing in egfr inhibition, hit-to-lead optimization, and small molecule tyrosine kinase inhibitors.

Publications per year

2015–2016

2

Publications

2

Design and discovery of 4-anilinoquinazoline-urea derivatives as dual TK inhibitors of EGFR and VEGFR-2

Haiqi Zhang, Fei-Hu Gong, Ji-Qing Ye et al. · European Journal of Medicinal Chemistry · 2016 · 85 citations · Full text

, , +13

Design and discovery of 4-anilinoquinazoline-acylamino derivatives as EGFR and VEGFR-2 dual TK inhibitors

Haiqi Zhang, Fei-Hu Gong, Chuan-Gui Li et al. · European Journal of Medicinal Chemistry · 2015 · 70 citations · Full text

, , +13

1–2 of 2